-
Site License
-
Site License
-
Enterprisewide
-
Enterprisewide
U.S. Infectious Disease Diagnostics Markets
Frost & Sullivan, April 2006
This Frost & Sullivan research service, titled U.S. Infectious Disease Diagnostics Markets, provides comprehensive analysis of market drivers, restraints, challenges, and trends. Moreover, analysis of market share, competitive structure, revenue forecasts, and products is included. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: molecular infectious disease diagnostics, immunoassay infectious disease diagnostics, and culture infectious disease diagnostics.
Market Sectors
Frost & Sullivan's expert analysts thoroughly examine the following market sectors in this research:
- Molecular
- Immunoassay
- Culture
Technologies
The following technologies are covered in this research:
- PCR
- Automated antimicrobial susceptibility testing
- Molecular technologies and assays
- Immunoassays
- Microbiology culture methods
Market Overview
The U.S. infectious disease diagnostics market will play a significant role in the dynamic IVD market. This market is segmented according to molecular, immunoassays, and culture infectious disease products. Total market revenues for base year 2005 are $3,823.1 with a CAGR of 7.7%. The most substantial growth is expected in the molecular segment. The U.S. infectious disease diagnostics market is highly competitive and saturated
Tremendous growth opportunities exist in the U.S. infectious disease in-vitro diagnostics market. High growth areas include viral load testing, nosocomial infection screening, rapid influenza detection, and STD testing.
Rapid detection and fast turn-around time (TAT) are able to lower total overall healthcare costs. Quick TAT is especially relevant to infectious disease testing, as fast diagnosis increases treatment options and patient prognosis.
Technical superiority of molecular methods is phasing out other types or more traditional methods, such as culture based tests, which have TATs of only days and are labor intensive.
1. Executive Summary
- 1. Executive Summary
- - 1. Executive Summary
2. Total Infectious Disease Diagnostics Market
- 1. Market Overview
- - 1. Introduction
- - 2. Research Methodology
- - 3. Market Engineering Analysis
- 2. Market Forecasts and Market Share Analysis
- - 1. Scope and Segmentation
- - 2. Market and Technology Trends
- - 3. Market Forecasts
- - 4. Market Share Analysis
- 3. Market Challenges and Strategic Recommendations
- - 1. Industry Challenges
- - 2. Strategic Recommendations
- 4. Frost & Sullivan Awards
- - 1. Market Leadership Award
- - 2. Product Line Strategy Award
- - 3. Technology Innovation Award
- - 4. Market Penetration Leadership Award
3. Molecular Infectious Disease Diagnostics Market
- 1. Market Overview and Forecasts
- - 1. Introduction
- - 2. Market Engineering Measurements
- - 3. Revenue Forecast
- 2. Market Drivers and Restraints
- - 1. Market Drivers
- - 2. Market Restraints
- 3. Competitive Analysis
- - 1. Competitive Structure
- - 2. Market Share Analysis
- - 3. Product Analysis
4. Immunoassay Infectious Disease Diagnostics Market
- 1. Market Overview and Forecasts
- - 1. Introduction
- - 2. Market Engineering Measurements
- - 3. Revenue Forecast
- 2. Market Drivers and Restraints
- - 1. Market Drivers
- - 2. Market Restraints
- 3. Competitive Analysis
- - 1. Competitive Structure
- - 2. Market Share Analysis
- - 3. Product Analysis
5. Culture Infectious Disease Diagnostics Market
- 1. Market Overview and Forecasts
- - 1. Introduction
- - 2. Market Engineering Measurements
- - 3. Revenue Forecast
- 2. Market Drivers and Restraints
- - 1. Market Drivers
- - 2. Market Restraints
- 3. Competitive Analysis
- - 1. Competitive Structure and Market Share Analysis
- - 2. Product Analysis
6. Appendix
- 1. Decision Support Database
- - 1. Global Incidence of TB
- - 2. Global Reported AIDS Cases
- - 3. Global AIDS Mortality Rates
- - 4. Global Incidence of Haemophilus Type B
- - 5. Global Incidence of Hepatitis A
- - 6. Global Incidence of Hepatitis B
- - 7. Global HIV Prevalence
- - 8. Global Incidence of Malaria
- - 9. Global Cases of Rubella
- - 10. Global Incidence of Syphilis
- - 11. U.S. Initial Physician Visit for Genital Herpes
- - 12. U.S. Incidence of Haemophilus Influenzae
- - 13. U.S. Cases of Chlamydia
- - 14. U.S. Cases of Gonorrhea
- - 15. U.S. Cases of West Nile Virus
List Of Figures
- Figure 2-1 Total Infectious Disease Diagnostics Market: Revenue Forecasts (U.S.), 2002-2012
- Figure 2-2 Total Infectious Disease Diagnostics Market: Percent of Revenues by Product Type (U.S.), 2002-2012
- Figure 2-3 Total Infectious Disease Diagnostics Market: Percentage of Total Revenue by Market Segment (U.S.), 2005
- Figure 2-4 Total Infectious Disease Diagnostics Market: Company Market Share by Revenues (U.S.), 2005
- Figure 2-5 Total Infectious Disease Diagnostics Market: Impact of Top Industry Challenges (U.S.), 2006-2012
- Figure 2-6 Total Infectious Disease Diagnostics Market: Impact of Strategic Recommendations on Business Functions (U.S.), 2006-2012
- Figure 3-1 Molecular Infectious Disease Diagnostics Market: Revenue Forecasts (U.S.), 2002-2012
- Figure 3-2 Molecular Infectious Disease Diagnostics Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
- Figure 3-3 Molecular Infectious Disease Diagnostics Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
- Figure 3-4 Molecular Infectious Disease Diagnostics Market: Competitive Structure (U.S.), 2005
- Figure 3-5 Molecular Infectious Disease Diagnostics Market: Market Share Trends of Major Market Participants (U.S.), 2004-2005
- Figure 3-6 Molecular Infectious Disease Diagnostics Market: CT/NG Market Share (U.S.), 2004-2005
- Figure 3-7 Molecular Infectious Disease Diagnostics Market: Key Industry Participants by Major Product Type (U.S.), 2005
- Figure 3-8 Molecular Infectious Disease Diagnostics Market: Market Share According to Testing Volume (U.S.), 2004-2005
- Figure 3-9 Molecular Infectious Disease Diagnostics Market: Products Offered by Major Market Participants (U.S.), 2005
- Figure 3-10 Molecular Infectious Disease Diagnostics Market: Product Pipeline Offered by Select Market Participants (U.S.), 2005
- Figure 3-11 Molecular Infectious Disease Diagnostics Market: Bacterial Infectious Disease Tests Offered by Major Market Participants (U.S.), 2005
- Figure 3-12 Molecular Infectious Disease Diagnostics Market: Viral Infectious Disease Tests Offered by Major Market Participants (U.S.), 2005
- Figure 3-13 Molecular Infectious Disease Diagnostics Market: Molecular Diagnostics Controls Offered by Major Market Participants (U.S.), 2005
- Figure 3-14 Molecular Infectious Disease Diagnostics Market: Molecular Diagnostics Systems Offered by Major Market Participants (U.S.), 2005
- Figure 4-1 Immunoassay Infectious Disease Diagnostics Market: Revenue Forecasts (U.S.), 2002-2012
- Figure 4-2 Immunoassay Infectious Disease Diagnostics Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
- Figure 4-3 Immunoassay Infectious Disease Diagnostics Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
- Figure 4-4 Immunoassay Infectious Disease Diagnostics Market: Competitive Structure (U.S.), 2005
- Figure 4-5 Immunoassay Infectious Disease Diagnostics Market: Company Market Share by Revenues (U.S.), 2005
- Figure 4-6 Infectious Disease Immunoassay Diagnostics Market: Select Assays Offered by Major Market Participants (U.S.), 2005
- Figure 4-7 Immunoassay Infectious Disease Diagnostics Market: Key Industry Participants by Major Product Type (U.S.), 2005
- Figure 5-1 Culture Infectious Disease Diagnostics Market: Total Market Revenue Forecasts (U.S.), 2002-2012
- Figure 5-2 Culture Infectious Disease Diagnostics Market: ID/AST Market Revenue Forecasts (U.S.), 2002-2012
- Figure 5-3 Culture Infectious Disease Diagnostics Market: Microbiology Culture Revenue Forecasts (U.S.), 2002-2012
- Figure 5-4 Culture Infectious Disease Diagnostics Market: Blood Culture Revenue Forecasts (U.S.), 2002-2012
- Figure 5-5 Culture Infectious Disease Diagnostics Market: Percent of Revenues by Product Type (U.S.), 2002-2012
- Figure 5-6 Culture Infectious Disease Diagnostics Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
- Figure 5-7 Culture Infectious Disease Diagnostics Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
- Figure 5-8 Culture Infectious Disease Diagnostics Market: Competitive Structure (U.S.), 2005
- Figure 5-9 Culture Infectious Disease Diagnostics Market: ID/AST Market Share by Revenues (U.S.), 2005
- Figure 5-10 Culture Infectious Disease Diagnostics Market: Company Market Share by Revenues (U.S.), 2005
- Figure 5-11 Culture Infectious Disease Diagnostics Market: Top Ten Bacteria of Medical Relavance (U.S.), 2005
List of Charts
- Chart 2.1 Total Infectious Disease Diagnostics Market: Market Engineering Measurements (U.S.), 2005
- Chart 2.2 Total Select Cell Culture Market: Product Life Cycle and Market Size (U.S.), 2005
- Chart 2.3 Total Infectious Disease Diagnostics Market: Revenue Forecasts (U.S.), 2002-2012
- Chart 2.4 Total Infectious Disease Diagnostics Market: Percent of Total Forecasts Revenues by Segment (U.S.), 2002-2012
- Chart 2.5 Total Infectious Disease Diagnostics Market: Percent of Total Revenues by Segment (U.S.), 2005
- Chart 2.6 Total Infectious Disease Diagnostics Market: Percent Market Share of Major Market Participants (U.S.), 2005
- Chart 3.1 Molecular Infectious Disease Diagnostics Market: Market Engineering Measurements (U.S.), 2005
- Chart 3.2 Molecular Infectious Disease Diagnostics Market: Revenue Forecast (U.S.), 2002-2012
- Chart 3.3 Molecular Infectious Disease Diagnostics Market: Competitive Structure (U.S.), 2005
- Chart 3.4 Molecular Infectious Disease Diagnostics Market: Company Market Share by Revenue (U.S.), 2005
- Chart 3.5 Molecular Infectious Disease Diagnostics Market: CT/NG Testing Company Market Share by Revenue (U.S.), 2005
- Chart 3.5 Molecular Infectious Disease Diagnostics Market: Infectious Disease Tests Market Share by Test Volume (U.S.), 2005
- Chart 4.1 Immunoassay Infectious Disease Diagnostics Market: Market Engineering Measurements (U.S.), 2005
- Chart 4.2 Immunoassay Infectious Disease Diagnostics Market: Revenue Forecasts (U.S.), 2002-2012
- Chart 4.3 Immunoassay Infectious Disease Diagnostics Market: Competitive Structure (U.S.), 2005
- Chart 4.4 Immunoassay Infectious Disease Diagnostics Market: Company Market Share by Revenue (U.S.), 2005
- Chart 5.1 Culture Infectious Disease Diagnostics Market: Market Engineering Measurements (U.S.), 2005
- Chart 5.2 Culture Infectious Disease Diagnostics Market: Revenue Forecasts (U.S.), 2002-2012
- Chart 5.3 Culture Infectious Disease Diagnostics Market: ID/AST Market Revenue Forecast (U.S), 2002-2012
- Chart 5.4 Culture Infectious Disease Diagnostics Market: Microbiology Culture Market Revenue Forecast (U.S.), 2002-2012
- Chart 5.5 Culture Infectious Disease Diagnostics Market: Blood Culture Revenue Forecast (U.S.), 2002-2012
- Chart 5.6 Culture Infectious Disease Diagnostics Market: Percent of Total Forecasts Revenues by Segment (U.S.), 2002-2012
- Chart 5.7 Culture Infectious Disease Diagnostics Market: Competitive Structure (U.S.), 2005
- Chart 5.8 Culture Infectious Disease Diagnostics Market: Percent Market Share of automated ID/AST Market (U.S.), 2005
- Chart 5.9 Culture Infectious Disease Diagnostics Market: Company Market Share by Revenue (U.S.), 2005
- Chart 5.10 Culture Infectious Disease Diagnostics Market: Percent Market Share of Product Type (U.S.), 2005
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
